MARY BOYETTE: Open Payments
NPI 1649745449 · ROY, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$807 in 39 payments from 19 companies in 2025. Trend: 2023 $379 · 2024 $1,132 · 2025 $807
Food & beverage: $707Education: $100
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 7 | $149 |
| Astellas Pharma US Inc | 2 | $117 |
| Axsome Therapeutics, Inc. | 5 | $101 |
| ABBVIE INC. | 4 | $84 |
| Lilly USA, LLC | 4 | $62 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $44 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Dexcom, Inc. | 1 | $21 |
Products named: NURTEC ODT, Auvelity, QULIPTA, MOUNJARO, JARDIANCE, ROTATEQ, CAPLYTA, Dexcom G6 Transmitter.
Industry payments across UT — which companies pay providers there.
